The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung

Human Pathology

Volumn 31, Issue 4, 2000, Pages 482-487

  Piyathilake, Chandrika J ^a,b,c   Frost, Andra R ^a,b,c   Weiss, Heidi ^a,b,c   Manne, Upender ^a,b,c   Heimburger, Douglas C ^a,b,c   Grizzle, William E ^a,b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Biomedical Research Building II   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Ep CAM; Lung; Monoclonal antibody; Neoplasms

Indexed keywords

GLYCOPROTEIN;

ARTICLE; BRONCHUS MUCOSA; CANCER STAGING; CANCER SURVIVAL; EPITHELIUM HYPERPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG SQUAMOUS CELL CARCINOMA; MALIGNANT TRANSFORMATION; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 0034023211     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hp.2000.6711     Document Type: Article

References (25)

1. Miller B.A. Ries L.A.G. Hankey B.F. SEER Cancer Statistics Review 1973–1990 National Cancer Institute, NIH Pub. No. 932789 1993 Department of Health and Human Services Bethesda, MD
2. Shopland D.R. Eyre H.J. Pechacek T.F. Smoking-attributable cancer mortality in 1991: Is lung cancer now the leading cause of death among smokers in the United States? J Natl Cancer Inst 83 1991 1142 1148
3. Ihde D.C. Minna J.D. Non small cell lung cancer. Part I: Biology, diagnosis and staging Curr Probl Cancer 15 1991 65 147
4. Mountain C.F. Biologic, physiologic, and technical determinants in surgical therapy for lung cancer Strauss M.J. Lung Cancer, Clinical Diagnosis and Treatment 1983 Grune and Stratton New York, NY 245 260
5. Naruke T. Goya T. Tsuchiya R. Prognosis and survival in resected lung carcinoma based on the new international staging system J Thorac Cardiovasc Surg 96 1988 440 447
6. Riethmuller G. Johnson J.P. Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers Curr Opin Immunol 4 1992 647 655
7. Spurr N.K. Durbin H. Sheer D. Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antibody AUAI Int J Cancer 38 1986 631 636
8. Litvinov S.V. Velders M.P. Bakker H.A. Ep-CAM: A human epithelial antigen is a homophilic cell-cell adhesion molecule J Cell Biol 125 1994 437 446
9. Goodwin R.A. Tuttle S.E. Bucci D.M. Tumor-associated antigen expression of primary and metastatic colon carcinomas detected by monoclonal antibody 17-1A Am J Clin Pathol 88 1987 462 467
10. Tandon A.K. Clark G.M. Chamness G.C. Association of the 323/A3 surface glycoprotein with tumor characteristics and behavior in human breast cancer Cancer Res 50 1990 3317 3321
11. Kievit E. Pinedo H.M. Schluper H.M. Comparison of monoclonal antibodies 17-1A and 323/A3: The influence of the affinity on tumor uptake and efficacy of radioimmunotherapy in humanovarian cancer xenografts Br J Cancer 73 1996 457 464
12. Quak J.J. Van Dongen G. Brakkee J.G. Production of a monoclonal antibody (K 931) to a squamous cell carcinoma associated antigen identified as the 17-1A antigen Hybridoma 9 1990 377 387
13. Poczatek R.B. Myers R.B. Manne U. Ep-CAM levels in prostatic adenocarcinoma and prostatic intraepithelial neoplasia J Urol 162 1999 1462 1466
14. Velders M.P. Van Rhijn C.M. Briaire I.H. Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model Cancer Res 55 1995 4398 4403
15. Riethmuller G. Schneider-Gadicke E. Schlimok G. Randomized trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma Lancet 343 1994 1177 1183
16. (abstr) LoBuglio A.F. Saleh M.N. Braddock J.M. A phase 1 trial of the humanized anti-EGP40 monoclonal antibody 3622W94 Proc Annu Meet Am Soc Clin Oncol 16 1997 A1562
17. Passlick B. Izbicki J.R. Kubuschok B. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer J Clin Oncol 12 1994 1827 1832
18. Kubuschok B. Passlick B. Izbicki J.R. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer J Clin Oncol 17 1999 19 24
19. fascicle 13 Colby T.V. Koss M.N. Travis W.D. Squamous cell carcinoma and variants Rosai J. Tumors of the Lower Respiratory Tract: Atlas of Tumor Pathology 1995 Armed Forces Institute of Pathology 157 178
20. Rosai J. ed 8 Ackerman's Surgical Pathology vol 2 1996 Mosby St Louis, MO 2587 2595
21. Manne U. Weiss H. Myres R.B. Nuclear accumulation of p53 in colorectal adenocarcinomas: Prognostic importance differs with race and location of the tumor Cancer 83 1998 2456 2467
22. Manne U. Myres R.B. Moron C. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma Int J Cancer 74 1997 346 358
23. Hung J. Kishimoto Y. Sugio K. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma J Am Med Assoc 273 1995 558 563
24. Roye G.D. Myers R.B. Brown D. CD44 expression in dysplastic epithelium and squamous cell carcinoma of the esophagus Int J Cancer (Pred Oncol) 69 1996 254 258
25. Benchimol S. Fuks A. Jothy S. Carcinoembryonic antigen function as an intracellular adhesion molecule Cell 57 1989 327 334